Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FORTITUDE: Neuromodulators and Cough Control Therapy in Refractory or Unexplained Chronic Cough
NCT07288528Phase 4Not yet recruiting
- Sponsor
- McMaster University
- Start
- Sep 2026
- Primary completion
- Sep 2029
- Countries
- 1
01
Overview
A Phase 4 trial of morphine, pregabalin in refractory chronic cough (RCC), unexplained chronic cough, sponsored by McMaster University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
morphinepregabalin
03
Conditions
refractory chronic cough (RCC)unexplained chronic cough
Beyond the preview
Go deeper on NCT07288528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07288528.